Art

J-GLOBAL ID：201102265068496571   Reference number：11A0504835

Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1)

進行乳癌を持つ閉経後日本人女性におけるフルベストラントの3用量レジメン

Author (11)： OHNO S. (National Kyushu Cancer Center, Fukuoka) ,  RAI Y. (Sagara Hospital, Kagoshima) ,  IWATA H. (Aichi Cancer Center Hospital, Nagoya) ,  YAMAMOTO N. (Chiba Cancer Center, Chiba) ,  YOSHIDA M. (Seirei Hamamatsu General Hospital, Shizuoka) ,  IWASE H. (Kumamoto Univ. Hospital, Kumamoto) ,  MASUDA N. (Osaka National Hospital, Osaka) ,  NAKAMURA S. (St Luke’s International Hospital, Tokyo) ,  TANIGUCHI H. (Japanese Red Cross Nagasaki Atomic Bomb Hospital, Nagasaki) ,  KAMIGAKI S. (Sakai Municipal Hospital, Osaka) ,  NOGUCHI S. (Osaka Univ. Graduate School of Medicine, Osaka, JPN)
Material： Annals of Oncology  (Ann Oncol)
Volume： 21  Issue： 12  Page： 2342-2347  Publication year： Dec. 2010 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： *breast tumor ,...
Semi thesaurus term： Breast Cancer ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0504835&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of female genitalia and fetus  (GS04000K)

Substance index (1)： Fulvestrant

Reference (19)：

• Addo S, Yates RA, Laight A. A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteers. Br J Cancer 2002; 87: 1354-1359.
• DeFriend DJ, Howell A, Nicholson RI et al. Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res 1994; 54: 408-414.
• Robertson JF, Nicholson RI, Bundred NJ et al. Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)- nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer. Cancer Res 2001; 61: 6739-6746.
• Wakeling AE. Similarities and distinctions in the mode of action of different classes of antioestrogens. Endocr Relat Cancer 2000; 7: 17-28.
• Chia S, Gradishar W, Mauriac L et al. Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT. J Clin Oncol 2008; 26: 1664-1670.

Terms in the title (7)： 進行乳癌 ,  閉経後 ,  日本人 ,  女性 ,  フルベストラント ,  用量 ,  レジメン